These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25808006)

  • 21. Expression and induction of cytochrome p450 isoenzymes in human skin equivalents.
    Neis MM; Wendel A; Wiederholt T; Marquardt Y; Joussen S; Baron JM; Merk HF
    Skin Pharmacol Physiol; 2010; 23(1):29-39. PubMed ID: 20090406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling.
    van Eijl S; Zhu Z; Cupitt J; Gierula M; Götz C; Fritsche E; Edwards RJ
    PLoS One; 2012; 7(7):e41721. PubMed ID: 22848577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Human drug metabolizing enzymes. II. Conjugation enzymes].
    Vereczkey L; Jemnitz K; Gregus Z
    Acta Pharm Hung; 1998 Sep; 68(5):284-8. PubMed ID: 9805814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of enzyme activities of Cytochrome P450 enzymes, Flavin-dependent monooxygenases, N-acetyltransferases and UDP-glucuronyltransferases in human reconstructed epidermis and full-thickness skin models.
    Jäckh C; Blatz V; Fabian E; Guth K; van Ravenzwaay B; Reisinger K; Landsiedel R
    Toxicol In Vitro; 2011 Sep; 25(6):1209-14. PubMed ID: 21435388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotransformation of drugs in human skin.
    Svensson CK
    Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder.
    Murray GI; Taylor VE; McKay JA; Weaver RJ; Ewen SW; Melvin WT; Burke MD
    Int J Exp Pathol; 1995 Aug; 76(4):271-6. PubMed ID: 7547441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
    McKim JM; Keller DJ; Gorski JR
    Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of xenobiotic enzymes in human skin in vitro models to activate pro-sensitizers.
    Jäckh C; Fabian E; van Ravenzwaay B; Landsiedel R
    J Immunotoxicol; 2012; 9(4):426-38. PubMed ID: 22471730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
    Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
    Haining RL; Nichols-Haining M
    Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the metabolism and hepatotoxicity of xenobiotics utilizing precision-cut slices.
    Lake BG; Price RJ
    Xenobiotica; 2013 Jan; 43(1):41-53. PubMed ID: 23131042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Cosmetics Europe strategy for animal-free genotoxicity testing: project status up-date.
    Pfuhler S; Fautz R; Ouedraogo G; Latil A; Kenny J; Moore C; Diembeck W; Hewitt NJ; Reisinger K; Barroso J
    Toxicol In Vitro; 2014 Feb; 28(1):18-23. PubMed ID: 23811264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highlight report: xenobiotic-metabolizing enzymes in skin models.
    Golka K
    Arch Toxicol; 2015 Dec; 89(12):2465-7. PubMed ID: 26621186
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes.
    Ginsberg G; Smolenski S; Neafsey P; Hattis D; Walker K; Guyton KZ; Johns DO; Sonawane B
    J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):307-33. PubMed ID: 20183525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolism of xenobiotics and its relationship to toxicity/genotoxicity: studies with human lymphocytes.
    Lundgren B; DePierre JW
    Acta Physiol Scand Suppl; 1990; 592():49-59. PubMed ID: 2267943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onset of xenobiotic metabolism in children: toxicological implications.
    Cresteil T
    Food Addit Contam; 1998; 15 Suppl():45-51. PubMed ID: 9602911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.
    Oesch F; Fabian E; Guth K; Landsiedel R
    Arch Toxicol; 2014 Dec; 88(12):2135-90. PubMed ID: 25370008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of xenobiotics of human environments.
    Croom E
    Prog Mol Biol Transl Sci; 2012; 112():31-88. PubMed ID: 22974737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M; Pelkonen O
    IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.